• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Presenting on Emerging Growth Conference 84 Day 1 on July 16; Register to live stream

    7/15/25 7:00:00 AM ET
    $ADVM
    $ASPI
    $BNZI
    $CLNN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Major Chemicals
    Industrials
    Get the next $ADVM alert in real time by email

    MIAMI, July 15, 2025 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 84th Emerging Growth Conference on July 16 & 17, 2025.

    The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth.

    Register for the Conference here.

    Submit Questions for any of the presenting companies to:

    [email protected]

    For updates, follow us on Twitter

    Day 1

    July 16, 2025

    8:45

    Virtual Lobby opens.

    Register for the Conference. If you already registered, go back to the registration link and click "Already registered" and enter your email.

    9:00

    Introduction

    9:05 – 9:35

    BitFuFu Inc. (NASDAQ:FUFU)

    Keynote speaker: Charley Brady, VP Investor Relations

    9:40 – 10:10

    Impact Minerals Limited (ASX: IPT)

    Keynote speaker: Dr. Mike Jones, Managing Director

    11:25 – 11:55

    Faraday Future Intelligent Electric, Inc. (NASDAQ:FFAI)

    Keynote speakers: Jerry Wang, Global President

    12:35 – 1:05

    Adverum Biotechnologies (NASDAQ:ADVM)

    Keynote speaker: Jason Awe, PhD, MBA, Corporate Communications & IR

    1:10 – 1:40

    GeoVax Labs, Inc. (NASDAQ:GOVX)

    Keynote speakers: David Dodd, Chairman, President / CEO

    3:10 - 3:20

    Banzai International, Inc. (NASDAQ:BNZI)

    Keynote speaker: Joseph Davy, Co-Founder, Chairman & CEO

    3:25 - 3:35

    Interstellar Communication Holdings 

    Keynote speakers: Seda Hewitt, Space Ambassador of IcMercury Harri Laitinen, Lifeguard  of IcMercury, and Lijie Zhu, Captain of icMercury

    3:40 – 3:50

    Vizsla Royalties Corp. (TSXV:VROY) (OTCQB:VROYF)

    Keynote speaker: Michael N. Pettingell, President and CEO

    4:10 – 4:20

    Cyios Corp. (OTC:CYIO)

    Keynote speaker: John O'Shea, Chairman

    _______________________________________________________________

    Day 2

    July 17, 2025

    8:45

    Virtual Lobby opens.

    Register for the Conference. If you already registered, go back to the registration link and click "Already registered" and enter your email.

    9:00

    Introduction

    9:05 – 9:35

    Argenica Therapeutics Limited (ASX:AGN)

    Keynote speaker: Dr. Liz Dallimore, CEO & Managing Director

    9:40 – 10:10

    Uxin Limited (NASDAQ:UXIN)

    Keynote speaker: Feng Lin, CFO

    10:15 – 10:45

    ASP Isotopes Inc. (NASDAQ:ASPI)

    Keynote speaker: Paul Elliot Mann, CEO

    11:25 – 11:55

    Surf Air Mobility, Inc. (NYSE:SRFM)

    Keynote speakers: Deanna White, CEO and Oliver Reeves, CFO

    2:55 – 3:05

    Jaguar Health, Inc. (NASDAQ:JAGX)

    Keynote speaker: Lisa A. Conte, Founder, CEO, President & Director

    3:10 - 3:20

    Clene Inc., (NASDAQ:CLNN)

    Keynote speakers: Rob Etherington, President / CEO

    3:25 – 3:35

    Sono Group N.V. (OTCQB:SEVCF)

    Keynote speaker: George O'Leary, Managing Director, CEO and CFO

    Visit the following link to register. You will then receive an email containing the link and time to sign into the conference.

    Register for the Conference here.

    Submit Questions for any of the presenting companies to:

    [email protected]

    Replays: Subscribe to our YouTube Channel

    About EmergingGrowth.com

    Founded in 2009, Emerging Growth.com quickly became a leader in its space and has developed an extensive history of identifying emerging growth companies that can be overlooked by the investment community.

    About the Emerging Growth Conference

    The Emerging Growth Conference is an effective way for public companies to engage with the investment community regarding their Company, new products, services and other major announcements from anywhere, in an effective and time efficient manner.

    All sessions are conducted through video webcasts. Our conference serves as a vehicle for Emerging Growth to build relationships with our existing and potential clients.  Accordingly, a certain number of the presenting companies are our current clients, and some may become our clients in the future.  In exchange for services we provide, our clients pay us fees in the form of cash and securities, and we may currently have, or in the future may have investments in the securities of certain of the presenting companies. Finally, certain of the presenting companies have paid us a fee to secure a presentation time slot or to present generally. The presentations to be delivered by the presenting companies (including any virtual handouts of written materials) have not been approved, endorsed by or otherwise reviewed by EmergingGrowth.com nor should they in any way be construed to have been made in connection with an offer to sell or a solicitation of an offer to buy securities. Please consult an investment professional before investing in anything viewed on the Emerging Growth Conference or on EmergingGrowth.com.

    If you believe or know of a company that might fit our audience, contact us here.

    Thank you for your interest in our conference, and we look forward to your participation in future conferences.

    Contact:

    Emerging Growth

    Phone: 1-305-330-1985

    Email: [email protected]



    Primary Logo

    Get the next $ADVM alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ADVM
    $ASPI
    $BNZI
    $CLNN

    CompanyDatePrice TargetRatingAnalyst
    ASP Isotopes Inc.
    $ASPI
    12/4/2025$13.00Overweight
    Cantor Fitzgerald
    Adverum Biotechnologies Inc.
    $ADVM
    11/17/2025Buy → Neutral
    H.C. Wainwright
    BitFuFu Inc.
    $FUFU
    8/13/2025$6.00Buy
    Roth Capital
    BitFuFu Inc.
    $FUFU
    7/18/2025Buy
    B. Riley Securities
    BitFuFu Inc.
    $FUFU
    6/18/2025$5.50Market Perform
    Northland Capital
    GeoVax Labs Inc.
    $GOVX
    4/15/2025$18.00 → $14.00Buy
    D. Boral Capital
    GeoVax Labs Inc.
    $GOVX
    4/15/2025$15.00 → $8.50Buy
    Alliance Global Partners
    Surf Air Mobility Inc.
    $SRFM
    4/2/2025$3.25Hold → Buy
    Canaccord Genuity
    More analyst ratings

    $ADVM
    $ASPI
    $BNZI
    $CLNN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Ugwumba Chidozie sold $1,725,735 worth of shares (257,795 units at $6.69) (SEC Form 4)

    4 - Clene Inc. (0001822791) (Issuer)

    12/18/25 5:08:26 PM ET
    $CLNN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Scientific Officer Chaturvedi Pravin R was granted 11,740 shares, increasing direct ownership by 5,929% to 11,938 units (SEC Form 4)

    4 - Jaguar Health, Inc. (0001585608) (Issuer)

    12/15/25 6:02:34 PM ET
    $JAGX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Bochnowski James J was granted 6,363 shares, increasing direct ownership by 12,237% to 6,415 units (SEC Form 4)

    4 - Jaguar Health, Inc. (0001585608) (Issuer)

    12/15/25 5:57:47 PM ET
    $JAGX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADVM
    $ASPI
    $BNZI
    $CLNN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CEO, PRESIDENT AND DIRECTOR Fischer Laurent bought $553,917 worth of shares (128,699 units at $4.30), increasing direct ownership by 177% to 201,513 units (SEC Form 4)

    4 - Adverum Biotechnologies, Inc. (0001501756) (Issuer)

    12/8/25 9:45:06 PM ET
    $ADVM
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    CHIEF OPERATING OFFICER Soparkar Peter bought $211,000 worth of shares (50,000 units at $4.22), increasing direct ownership by 166% to 80,189 units (SEC Form 4)

    4 - Adverum Biotechnologies, Inc. (0001501756) (Issuer)

    12/8/25 9:45:04 PM ET
    $ADVM
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Global Co-CEO Jia Yueting bought $177,223 worth of shares (98,000 units at $1.81), increasing direct ownership by 23% to 531,838 units (SEC Form 4)

    4 - FARADAY FUTURE INTELLIGENT ELECTRIC INC. (0001805521) (Issuer)

    9/9/25 7:02:05 PM ET
    $FFAI
    Auto Manufacturing
    Industrials

    $ADVM
    $ASPI
    $BNZI
    $CLNN
    SEC Filings

    View All

    SEC Form 6-K filed by Uxin Limited

    6-K - Uxin Ltd (0001729173) (Filer)

    12/18/25 9:00:11 AM ET
    $UXIN
    Real Estate

    ASP Isotopes Inc. filed SEC Form 8-K: Regulation FD Disclosure

    8-K - ASP Isotopes Inc. (0001921865) (Filer)

    12/18/25 7:34:11 AM ET
    $ASPI
    Major Chemicals
    Industrials

    Banzai International Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits

    8-K - Banzai International, Inc. (0001826011) (Filer)

    12/17/25 5:01:26 PM ET
    $BNZI
    Computer Software: Prepackaged Software
    Technology

    $ADVM
    $ASPI
    $BNZI
    $CLNN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Uxin Reports Unaudited Financial Results for the Quarter Ended September 30, 2025 and Announces Entry into Definitive Agreement for Financing

    BEIJING, Dec. 18, 2025 /PRNewswire/ -- Uxin Limited ("Uxin" or the "Company") (NASDAQ:UXIN), China's leading used car retailer, today announced its unaudited financial results for the quarter ended September 30, 2025. Highlights for the Quarter Ended September 30, 2025 Transaction volume was 15,904 units for the three months ended September 30, 2025, an increase of 37.0% from 11,606 units in the last quarter and an increase of 125.7% from 7,046 units in the same period last year.Retail transaction volume was 14,020 units for the three months ended September 30, 2025, an increase of 35.0% from 10,385 units in the last quarter and an increase of 133.5% from 6,005 units in the same period last

    12/18/25 2:00:00 AM ET
    $UXIN
    Real Estate

    ASP Isotopes Inc. Announces Receipt of Regulatory Approvals for Acquisition of Renergen Limited

    WASHINGTON, Dec. 17, 2025 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI ("ASP Isotopes" or the "Company"), an advanced materials company dedicated to the development of technology and processes for the production of isotopes for use in multiple industries, today announced that all required regulatory approvals and clearances have been obtained for ASP Isotopes' proposed offer to acquire all of the issued ordinary shares of JSE-listed Renergen Limited ("Renergen"), pursuant to a scheme of arrangement under South African law pursuant to which Renergen shareholders will receive 0.09196 new ASP Isotopes shares for each Renergen share held on the record date (the "Scheme"). Accordingly, a

    12/17/25 9:30:00 AM ET
    $ASPI
    Major Chemicals
    Industrials

    AIxC Appoints Andrew Grossman As Head of Legal Where He Will Direct the Company's Legal, Compliance, and Governance Strategy

    LOS ANGELES, Dec. 17, 2025 /PRNewswire/ -- AIxCrypto Inc. (NASDAQ:AIXC, ", AIxC", or ", the Company", )) today announced the appointment of Andrew Grossman as Head of Legal. In this role, Andrew will direct the Company's legal, compliance, and governance functions, managing key areas including SEC disclosures, fund and investment compliance, digital asset and Web3 protocol architecture, and major strategic and commercial agreements. Andrew brings extensive experience in securities regulation, digital asset ecosystem architecture, strategic corporate structuring, IP strategy, a

    12/17/25 1:01:00 AM ET
    $AIXC
    $FFAI
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Auto Manufacturing
    Industrials

    $ADVM
    $ASPI
    $BNZI
    $CLNN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Cantor Fitzgerald initiated coverage on ASP Isotopes with a new price target

    Cantor Fitzgerald initiated coverage of ASP Isotopes with a rating of Overweight and set a new price target of $13.00

    12/4/25 8:40:44 AM ET
    $ASPI
    Major Chemicals
    Industrials

    Adverum Biotech downgraded by H.C. Wainwright

    H.C. Wainwright downgraded Adverum Biotech from Buy to Neutral

    11/17/25 9:39:07 AM ET
    $ADVM
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Roth Capital initiated coverage on BitFuFu with a new price target

    Roth Capital initiated coverage of BitFuFu with a rating of Buy and set a new price target of $6.00

    8/13/25 8:06:38 AM ET
    $FUFU
    Finance: Consumer Services
    Finance

    $ADVM
    $ASPI
    $BNZI
    $CLNN
    Leadership Updates

    Live Leadership Updates

    View All

    AIxC Appoints Andrew Grossman As Head of Legal Where He Will Direct the Company's Legal, Compliance, and Governance Strategy

    LOS ANGELES, Dec. 17, 2025 /PRNewswire/ -- AIxCrypto Inc. (NASDAQ:AIXC, ", AIxC", or ", the Company", )) today announced the appointment of Andrew Grossman as Head of Legal. In this role, Andrew will direct the Company's legal, compliance, and governance functions, managing key areas including SEC disclosures, fund and investment compliance, digital asset and Web3 protocol architecture, and major strategic and commercial agreements. Andrew brings extensive experience in securities regulation, digital asset ecosystem architecture, strategic corporate structuring, IP strategy, a

    12/17/25 1:01:00 AM ET
    $AIXC
    $FFAI
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Auto Manufacturing
    Industrials

    Faraday Future Founder and Co-CEO YT Jia Shares Weekly Investor Update: FX Officially Enters the Florida Market with the Signing of Golden Hills Investment LLC who Made a Deposit Agreement for 2,000 FX Super One MPVs

    The FX Super One First Pre-Production Vehicles Roll-off Ceremony is scheduled for December 21 at the Company's manufacturing facility in Hanford, CA.FX has entered the Florida market with the signing of Golden Hills Investment LLC, a Florida-based high-end vacation rental investor and operator company. They made a deposit agreement for 2,000 FX Super One MPV's, including non-refundable deposits and non-binding pre-orders. LOS ANGELES, Dec. 14, 2025 (GLOBE NEWSWIRE) -- Faraday Future Intelligent Electric Inc. (NASDAQ:FFAI) ("Faraday Future", "FF" or the "Company"), a California-based global shared intelligent electric mobility ecosystem company, today shared a weekly business update from Y

    12/14/25 7:30:00 PM ET
    $FFAI
    Auto Manufacturing
    Industrials

    BitFuFu to Update Investors at the Emerging Growth Conference on December 11, 2025

    SINGAPORE, Dec. 09, 2025 (GLOBE NEWSWIRE) -- BitFuFu Inc. ("BitFuFu" or the "Company") (NASDAQ:FUFU), a world-leading Bitcoin miner and mining services innovator, today announced that it will provide a brief update to investors at the Emerging Growth Conference on December 11, 2025. This live, interactive online event will give existing shareholders and the investment community the opportunity to interact with the Company's Vice President of Investor Relations, Charley Brady, who will present an update and, time permitting, open the floor for questions. Please submit your questions in advance to [email protected] or ask your questions during the event. BitFuFu will be presenti

    12/9/25 11:00:00 AM ET
    $FUFU
    Finance: Consumer Services
    Finance

    $ADVM
    $ASPI
    $BNZI
    $CLNN
    Financials

    Live finance-specific insights

    View All

    Uxin Reports Unaudited Financial Results for the Quarter Ended September 30, 2025 and Announces Entry into Definitive Agreement for Financing

    BEIJING, Dec. 18, 2025 /PRNewswire/ -- Uxin Limited ("Uxin" or the "Company") (NASDAQ:UXIN), China's leading used car retailer, today announced its unaudited financial results for the quarter ended September 30, 2025. Highlights for the Quarter Ended September 30, 2025 Transaction volume was 15,904 units for the three months ended September 30, 2025, an increase of 37.0% from 11,606 units in the last quarter and an increase of 125.7% from 7,046 units in the same period last year.Retail transaction volume was 14,020 units for the three months ended September 30, 2025, an increase of 35.0% from 10,385 units in the last quarter and an increase of 133.5% from 6,005 units in the same period last

    12/18/25 2:00:00 AM ET
    $UXIN
    Real Estate

    Uxin to Report Third Quarter 2025 Financial Results on December 18, 2025

    BEIJING, Dec. 12, 2025 /PRNewswire/ -- Uxin Limited ("Uxin" or the "Company") (NASDAQ:UXIN), China's leading used car retailer, today announced that it will release its financial results for the third quarter 2025 ended September 30, 2025, before the U.S. market opens on December 18, 2025. Uxin's management team will host a conference call on Thursday, December 18, 2025, at 8:00 A.M. U.S. Eastern Time (9:00 P.M. Beijing/Hong Kong time on the same day) to discuss the financial results. In advance of the conference call, all participants must use the following link to complete the online registration process. Upon registering, each participant will receive access details for this conference i

    12/12/25 3:00:00 AM ET
    $UXIN
    Real Estate

    Clene Announces Statistically Significant ALS Biomarker Results Supporting Accelerated Approval Pathway for CNM-Au8®

    FDA recommended biomarker analyses show statistically significant reductions in NfL and GFAP in participants treated with CNM-Au8Biomarker improvements are strongly associated with longer survival, reinforcing CNM-Au8's potential disease modifying activityCompany has requested a Type C meeting in the first quarter of 2026 to present the newly completed analyses supporting a planned NDA submission under the accelerated approval pathwayClene is hosting an investor webcast today at 8:30 am ET SALT LAKE CITY, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Clene Inc. (NASDAQ:CLNN) (along with its subsidiaries, "Clene" or the "Company") and its wholly owned subsidiary Clene Nanomedicine, Inc., a late clinic

    12/3/25 8:00:00 AM ET
    $CLNN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADVM
    $ASPI
    $BNZI
    $CLNN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Adverum Biotechnologies Inc.

    SC 13G/A - Adverum Biotechnologies, Inc. (0001501756) (Subject)

    11/14/24 6:57:12 PM ET
    $ADVM
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form SC 13G/A filed by Adverum Biotechnologies Inc.

    SC 13G/A - Adverum Biotechnologies, Inc. (0001501756) (Subject)

    11/14/24 6:40:56 PM ET
    $ADVM
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form SC 13G/A filed by GeoVax Labs Inc.

    SC 13G/A - GeoVax Labs, Inc. (0000832489) (Subject)

    11/14/24 5:10:48 PM ET
    $GOVX
    Biotechnology: Pharmaceutical Preparations
    Health Care